bioRxivPhysiologyPreprint
Glucocorticoid chrono-pharmacology unveils novel targets for the cardiomyocyte-specific GR-KLF15 axis in cardiac glucose metabolism
F. El Abdellaoui-Soussi, H. B. Durumutla, H. Latimer, A. D. Prabakaran, K. McFarland, K. Miz, K. Piczer, C. Werbrich, M. K. Jain, S. M. Haldar, M. Quattrocelli
Abstract
Circadian time-of-intake gates the cardioprotective effects of glucocorticoid administration in both healthy and infarcted hearts. The cardiomyocyte-specific glucocorticoid receptor (GR) and its co-factor, Kruppel-like factor (Klf15), play critical roles in maintaining normal heart function in the long-term and serve as pleiotropic regulators of cardiac metabolism. Despite this understanding, the cardiomyocyte-autonomous metabolic targets influenced by the concerted epigenetic action of GR-Klf15 axis remain undefined. Here, we demonstrate the critical roles of the cardiomyocyte-specific GR and Klf15 in orchestrating a circadian-dependent glucose oxidation program within the heart. Combining integrated transcriptomics and epigenomics with cardiomyocyte-specific inducible ablation of GR or Klf15, we identified their synergistic role in the activation of adiponectin receptor expression (Adipor1) and the mitochondrial pyruvate complex (Mpc1/2), thereby enhancing insulin-stimulated glucose uptake and pyruvate oxidation. Furthermore, in obese diabetic (db/db) mice exhibiting insulin resistance and impaired glucose oxidation, light-phase prednisone administration, as opposed to dark-phase prednisone dosing, effectively restored cardiomyocyte glucose oxidation and improved diastolic function towards control-like levels in a sex-independent manner. Collectively, our findings uncover novel cardiomyocyte-autonomous metabolic targets of the GR-Klf15 axis. This study highlights the circadian-dependent cardioprotective effects of glucocorticoids on cardiomyocyte glucose metabolism, providing critical insights into chrono-pharmacological strategies for glucocorticoid therapy in cardiovascular disease. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=63 SRC="FIGDIR/small/572210v3_ufig1.gif" ALT="Figure 1"> View larger version (19K): org.highwire.dtl.DTLVardef@cf4b3corg.highwire.dtl.DTLVardef@1547db1org.highwire.dtl.DTLVardef@7f85aorg.highwire.dtl.DTLVardef@141fe94_HPS_FORMAT_FIGEXP M_FIG C_FIG Brief summaryDepending on when it is taken during the day, the drug prednisone activates the heart to
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Klf9 plays a critical role in GR dependent metabolic adaptations in cardiomyocytes
C. Thakkar, S. Alikunju, … D. Sayed·bioRxiv·May 8, 2023
- Impact of circadian time of dosing on cardiomyocyte-autonomous effects of glucocorticoids
M. Wintzinger, M. Panta, … M. Quattrocelli·bioRxiv·Dec 30, 2021
- Glucocorticoid Receptor ablation promotes cardiac regeneration by hampering cardiomyocyte terminal differentiation
- GLUCOCORTICOIDS REGULATE MITOCHONDRIAL FATTY ACID OXIDATION IN FETAL CARDIOMYOCYTES
J. R. Ivy, R. N. Carter, … K. Chapman·bioRxiv·Apr 30, 2021
- Harnessing glucocorticoid receptor antagonization to enhance the efficacy of cardiac regenerative growth factors and cytokines
Silvia Da Pra, Stefano Boriati, … Gabriele D’Uva·Nature Cardiovascular ResearchPeer-reviewed·Feb 6, 2026
- Constitutive expression of cardiomyocyte Klf9 precipitates metabolic dysfunction and spontaneous heart failure.
Chandni S. Thakkar, Saleena Alikunju, … Danish H Sayed·bioRxiv·Jan 16, 2025